IDiyas

For the Inventor, By the Inventor

Sudbury, MA, United States of America

David M Armistead

USPTO Granted Patents = 36 

 

Average Co-Inventor Count = 4.2

ph-index = 16

Forward Citations = 966(Granted Patents)


Location History:

  • Maynard, MA (US) (1994 - 2008)
  • Sudbury, MA (US) (2002 - 2023)

Company Filing History:

goldMedal22 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal3 out of 1,970 
 
Amgen Inc.
 patents
bronzeMedal3 out of 30 
 
Gilead Connecticut, Inc.
 patents
4. 3 out of 14 
 
Sirtris Pharmaceuticals, Inc.
 patents
5. 2 out of 4 
 
Warp Drive Bio, Inc.
 patents
6. 2 out of 35 
 
Revolution Medicines, Inc.
 patents
7. 1 out of 832,680 
Other
 patents

Years Active: 1994-2023

Loading Chart...
Loading Chart...
36 patents (USPTO):
1. 11644460 - Identifying new therapeutic agents (2023-05-09),
2. 10989710 - Identifying new therapeutic agents (2021-04-27),
3. 10203323 - Identifying new therapeutic agents (2019-02-12),
4. 9796718 - 6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine (2017-10-24),
5. 9428845 - Identifying new therapeutic agents (2016-08-30),
6. 8748607 - Imidazopyrizine syk inhibitors (2014-06-10),
7. 8455493 - Imidazopyrazine Syk inhibitors (2013-06-04),
8. 8178536 - Sirtuin modulating compounds (2012-05-15),
9. 8088928 - Sirtuin modulating compounds (2012-01-03),
10. 7855289 - Sirtuin modulating compounds (2010-12-21),
11. 7527952 - Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA) (2009-05-05),
12. 7329681 - Inhibitors of IMPDH enzyme (2008-02-12),
13. 7282504 - Kinase inhibitors (2007-10-16),
14. 7216041 - Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket (2007-05-08),
15. 7074789 - Kinase inhibitors (2006-07-11),

Title: David M Armistead - Innovator in Therapeutic Agents

Introduction

David M Armistead, based in Sudbury, MA, is an accomplished inventor with a remarkable portfolio of 36 patents. His innovative work primarily focuses on the identification of new therapeutic agents, contributing significantly to the field of pharmaceuticals.

Latest Patents

Among his latest contributions, Armistead has patented methods for identifying novel drug candidates. These patents represent significant advancements in the search for effective therapeutic solutions and showcase his expertise in medical innovation.

Career Highlights

Throughout his career, Armistead has worked with esteemed companies such as Vertex Pharmaceuticals, Inc. and Amgen Inc. His extensive experience in these leading organizations has equipped him with the knowledge and skills necessary to drive forward the development of new medical technologies.

Collaborations

David has collaborated with notable individuals in the industry, including Jeffrey O Saunders and Perry M Novak. These partnerships have fostered an environment of creativity and innovation, further enhancing the potential impact of his work in therapeutic discovery.

Conclusion

David M Armistead stands out as a key figure in the realm of therapeutic innovation. His impressive portfolio of patents and collaborations underscores his dedication to advancing the pharmaceutical industry and improving patient care. Through his ongoing efforts, he continues to pave the way for new possibilities in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…